Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival
- PMID: 7560600
- DOI: 10.1016/0735-1097(95)00258-0
Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival
Abstract
Objectives: We attempted to determine whether a family history of severe cardiovascular disease in patients with the Marfan syndrome is associated with increased aortic dilation or decreased survival, or both.
Background: The prognostic importance of a family history of severe cardiovascular disease in patients with the Marfan syndrome has been incompletely examined. We hypothesized that such a family history would correlate with increased aortic dilation and would be associated with decreased survival.
Methods: One hundred eight affected patients and 48 unaffected family members from 33 multigenerational families with the Marfan syndrome underwent echocardiographic measurement of the aortic root, arch and mid-abdominal aorta. Date of birth and age at death ascertained from family pedigrees were used to perform life table analysis and estimate survival.
Results: Aortic root and arch diameters were significantly greater in patients with a family history of severe cardiovascular disease than in patients without such a family history. Of subjects in the highest quartile for aortic size, > 80% had such a family history in contrast to < 10% of those in the lowest quartile (chi-square 57.37, p < 0.00001). Mean age at death and cumulative probability of survival were significantly lower in patients with such a family history.
Conclusions: Among patients with the Marfan syndrome, aortic dilation is greater and life expectancy shorter in those with a family history of severe cardiovascular manifestations. These data suggest that such a family history is an important risk factor for cardiovascular events in patients with the Marfan syndrome.
Similar articles
-
Dilation of peripheral vessels in Marfan syndrome: importance of thoracoabdominal MR angiography.Int J Cardiol. 2013 Sep 10;167(6):2928-31. doi: 10.1016/j.ijcard.2012.08.001. Epub 2012 Sep 4. Int J Cardiol. 2013. PMID: 22954416
-
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.Verh K Acad Geneeskd Belg. 2009;71(6):335-71. Verh K Acad Geneeskd Belg. 2009. PMID: 20232788 Review.
-
Long-term outcomes of aortic root operations for Marfan syndrome: A comparison of Bentall versus aortic valve-sparing procedures.J Thorac Cardiovasc Surg. 2016 Feb;151(2):330-6. doi: 10.1016/j.jtcvs.2015.10.068. Epub 2015 Oct 27. J Thorac Cardiovasc Surg. 2016. PMID: 26704057
-
Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.J Pediatr. 2007 Jan;150(1):77-82. doi: 10.1016/j.jpeds.2006.09.003. J Pediatr. 2007. PMID: 17188619
-
Marfan syndrome: literature review of mortality studies.J Insur Med. 2000;32(2):79-88. J Insur Med. 2000. PMID: 15912906 Review.
Cited by
-
Marfan syndrome: An eyesight of syndrome.Meta Gene. 2014 Jan 14;2:96-105. doi: 10.1016/j.mgene.2013.10.008. eCollection 2014 Dec. Meta Gene. 2014. PMID: 25606393 Free PMC article. Review.
-
Marfan syndrome in children and adolescents: predictive and prognostic value of aortic root growth for screening for aortic complications.Heart. 1998 Aug;80(2):163-9. doi: 10.1136/hrt.80.2.163. Heart. 1998. PMID: 9813564 Free PMC article.
-
Survival and complication free survival in Marfan's syndrome: implications of current guidelines.Heart. 1999 Oct;82(4):499-504. doi: 10.1136/hrt.82.4.499. Heart. 1999. PMID: 10490568 Free PMC article.
-
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.J Am Coll Cardiol. 2022 Dec 13;80(24):e223-e393. doi: 10.1016/j.jacc.2022.08.004. Epub 2022 Nov 2. J Am Coll Cardiol. 2022. PMID: 36334952 Free PMC article.
-
Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan's syndrome.Can J Cardiol. 2010 Mar;26(3):e80-97. doi: 10.1016/s0828-282x(10)70355-x. Can J Cardiol. 2010. PMID: 20352138 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical